Phase 2b Randomized Trial of the Oral PCSK9 Inhibitor MK-0616.
Ballantyne CM, Banka P, Mendez G, Garcia R, Rosenstock J, Rodgers A, Mendizabal G, Mitchel Y, Catapano AL.
Ballantyne CM, et al. Among authors: mitchel y.
J Am Coll Cardiol. 2023 Apr 25;81(16):1553-1564. doi: 10.1016/j.jacc.2023.02.018. Epub 2023 Mar 6.
J Am Coll Cardiol. 2023.
PMID: 36889610
Free article.
Clinical Trial.